GR3035587T3 - Thienobenzodiazepine derivatives for treatment of CNS disorders. - Google Patents
Thienobenzodiazepine derivatives for treatment of CNS disorders.Info
- Publication number
- GR3035587T3 GR3035587T3 GR20010400431T GR20010400431T GR3035587T3 GR 3035587 T3 GR3035587 T3 GR 3035587T3 GR 20010400431 T GR20010400431 T GR 20010400431T GR 20010400431 T GR20010400431 T GR 20010400431T GR 3035587 T3 GR3035587 T3 GR 3035587T3
- Authority
- GR
- Greece
- Prior art keywords
- treatment
- cns disorders
- alkyl
- optionally substituted
- thienobenzodiazepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929211379A GB9211379D0 (en) | 1992-05-29 | 1992-05-29 | Pharmaceutical compounds |
| GB939309025A GB9309025D0 (en) | 1993-04-30 | 1993-04-30 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3035587T3 true GR3035587T3 (en) | 2001-06-29 |
Family
ID=26300951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20010400431T GR3035587T3 (en) | 1992-05-29 | 2001-03-15 | Thienobenzodiazepine derivatives for treatment of CNS disorders. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0582368B1 (el) |
| JP (1) | JP3219541B2 (el) |
| CN (1) | CN1043994C (el) |
| AT (1) | ATE198891T1 (el) |
| AU (1) | AU668159B2 (el) |
| CA (1) | CA2097016A1 (el) |
| CZ (1) | CZ282783B6 (el) |
| DE (1) | DE69329887T2 (el) |
| DK (1) | DK0582368T3 (el) |
| ES (1) | ES2153373T3 (el) |
| FI (1) | FI101538B1 (el) |
| GR (1) | GR3035587T3 (el) |
| HU (1) | HU218278B (el) |
| IL (1) | IL105827A (el) |
| MX (1) | MX9303124A (el) |
| MY (1) | MY109943A (el) |
| NO (1) | NO305125B1 (el) |
| NZ (1) | NZ247703A (el) |
| PT (1) | PT582368E (el) |
| RU (1) | RU2125574C1 (el) |
| TW (1) | TW268005B (el) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5457101A (en) * | 1994-06-03 | 1995-10-10 | Eli Lilly And Company | Thieno[1,5]benzoidiazepine use |
| US5574028A (en) * | 1994-10-31 | 1996-11-12 | Eli Lilly And Company | Method for treating anxiety |
| EG23659A (en) * | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
| CR5278A (es) * | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
| EG24221A (en) * | 1995-03-24 | 2008-11-10 | Lilly Co Eli | Process for preparing olanzapine |
| US5891461A (en) * | 1995-09-14 | 1999-04-06 | Cygnus, Inc. | Transdermal administration of olanzapine |
| BR9708246A (pt) * | 1996-03-25 | 1999-07-27 | Lilly Co Eli | Metodo para tratamento de dor |
| IL126063A (en) * | 1996-03-25 | 2002-04-21 | Lilly Co Eli | Medicinal products containing ulanzapine for the treatment of migraine pain |
| CZ296263B6 (cs) * | 1996-03-25 | 2006-02-15 | Eli Lilly And Company | Farmaceutická kompozice pro lécení bolesti a jejípouzití |
| ZA978515B (en) * | 1996-09-23 | 1999-03-23 | Lilly Co Eli | Intermediates and process for preparing olanzapine |
| ID21924A (id) * | 1996-09-23 | 1999-08-12 | Lilly Co Eli | Olanzapin dihidrat d |
| CN1230883A (zh) * | 1996-09-24 | 1999-10-06 | 伊莱利利公司 | 包衣颗粒制剂 |
| AU2013305907B2 (en) | 2012-08-21 | 2018-01-18 | Saladax Biomedical Inc. | Antibodies to quetiapine and use thereof |
| CA2882597C (en) | 2012-08-21 | 2020-04-14 | Ortho-Clinical Diagnostics, Inc. | Antibodies to quetiapine haptens and use thereof |
| EP2888287A4 (en) | 2012-08-21 | 2016-04-20 | Ortho Clinical Diagnostics Inc | ANTIBODIES AGAINST PALIPERIDONE HAPTENES AND THEIR USE |
| JP6339569B2 (ja) | 2012-08-21 | 2018-06-06 | ヤンセン ファーマシューティカ エヌ．ベー． | リスペリドンへの抗体及びその使用 |
| AU2013305879B2 (en) | 2012-08-21 | 2017-10-12 | Saladax Biomedical Inc. | Antibodies to aripiprazole and use thereof |
| CA2882596C (en) | 2012-08-21 | 2019-05-14 | Ortho-Clinical Diagnostics, Inc. | Antibodies to olanzapine and use thereof |
| TR201910347T4 (tr) | 2012-08-21 | 2019-07-22 | Janssen Pharmaceutica Nv | Olanzapin haptenlerine yönelik antikorlar ve bunların kullanımı. |
| EP2888234B1 (en) | 2012-08-21 | 2017-12-06 | Janssen Pharmaceutica NV | Haptens of aripiprazole and their use in immunoassays |
| WO2014031587A1 (en) * | 2012-08-21 | 2014-02-27 | Janssen Pharmaceutica Nv | Haptens of olanzipine |
| TR201809424T4 (tr) | 2012-08-21 | 2018-07-23 | Janssen Pharmaceutica Nv | Risperidon ve paliperidon haptenleri. |
| CN104736567B (zh) | 2012-08-21 | 2019-09-03 | 詹森药业有限公司 | 阿立哌唑半抗原的抗体及其用途 |
| PT2888258T (pt) | 2012-08-21 | 2019-08-21 | Janssen Pharmaceutica Nv | Hapteno de paliperidona |
| CN104736561B (zh) | 2012-08-21 | 2018-06-12 | 詹森药业有限公司 | 帕潘立酮的抗体及其用途 |
| CN108517014A (zh) | 2012-08-21 | 2018-09-11 | 詹森药业有限公司 | 利培酮半抗原的抗体及其用途 |
| ES2645433T3 (es) | 2012-08-21 | 2017-12-05 | Janssen Pharmaceutica, N.V. | Haptenos de quetiapina para su uso en inmunoensayos |
| WO2017106508A1 (en) | 2015-12-17 | 2017-06-22 | Janssen Pharmaceutica Nv | Antibodies to quetiapine and use thereof |
| US10444250B2 (en) | 2015-12-17 | 2019-10-15 | Janssen Pharmaceutica Nv | Antibodies to risperidone and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU629879A3 (ru) * | 1974-11-26 | 1978-10-25 | Лилли Индастриз Лимитед, (Фирма) | Способ получени тиено(1,5) бензодиазепинов или их солей |
| SE7610219L (sv) * | 1975-09-24 | 1977-03-25 | Sandoz Ag | Nya dibenso /b,e//1,4/ diazepiner |
| GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
-
1993
- 1993-05-26 DE DE69329887T patent/DE69329887T2/de not_active Expired - Fee Related
- 1993-05-26 TW TW082104161A patent/TW268005B/zh active
- 1993-05-26 AT AT93304102T patent/ATE198891T1/de not_active IP Right Cessation
- 1993-05-26 NZ NZ247703A patent/NZ247703A/en unknown
- 1993-05-26 NO NO931917A patent/NO305125B1/no not_active IP Right Cessation
- 1993-05-26 PT PT93304102T patent/PT582368E/pt unknown
- 1993-05-26 DK DK93304102T patent/DK0582368T3/da active
- 1993-05-26 EP EP93304102A patent/EP0582368B1/en not_active Expired - Lifetime
- 1993-05-26 ES ES93304102T patent/ES2153373T3/es not_active Expired - Lifetime
- 1993-05-26 CA CA002097016A patent/CA2097016A1/en not_active Abandoned
- 1993-05-26 AU AU39807/93A patent/AU668159B2/en not_active Ceased
- 1993-05-27 MX MX9303124A patent/MX9303124A/es not_active IP Right Cessation
- 1993-05-28 HU HU9301579A patent/HU218278B/hu not_active IP Right Cessation
- 1993-05-28 CN CN93108212A patent/CN1043994C/zh not_active Expired - Fee Related
- 1993-05-28 IL IL10582793A patent/IL105827A/xx not_active IP Right Cessation
- 1993-05-28 MY MYPI93001036A patent/MY109943A/en unknown
- 1993-05-28 FI FI932445A patent/FI101538B1/fi active
- 1993-05-28 CZ CZ931024A patent/CZ282783B6/cs not_active IP Right Cessation
- 1993-05-28 JP JP12642993A patent/JP3219541B2/ja not_active Expired - Fee Related
- 1993-05-28 RU RU93005057A patent/RU2125574C1/ru active
-
2001
- 2001-03-15 GR GR20010400431T patent/GR3035587T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO305125B1 (no) | 1999-04-06 |
| EP0582368A1 (en) | 1994-02-09 |
| HU9301579D0 (en) | 1993-09-28 |
| CZ102493A3 (en) | 1993-12-15 |
| IL105827A0 (en) | 1993-09-22 |
| DE69329887D1 (de) | 2001-03-01 |
| ATE198891T1 (de) | 2001-02-15 |
| CN1043994C (zh) | 1999-07-07 |
| IL105827A (en) | 1997-02-18 |
| JPH0687862A (ja) | 1994-03-29 |
| CA2097016A1 (en) | 1993-11-30 |
| PT582368E (pt) | 2001-05-31 |
| NO931917L (no) | 1993-11-30 |
| NZ247703A (en) | 1995-07-26 |
| ES2153373T3 (es) | 2001-03-01 |
| MY109943A (en) | 1997-10-31 |
| MX9303124A (es) | 1993-11-01 |
| CN1085903A (zh) | 1994-04-27 |
| HU218278B (en) | 2000-07-28 |
| FI101538B (fi) | 1998-07-15 |
| RU2125574C1 (ru) | 1999-01-27 |
| AU668159B2 (en) | 1996-04-26 |
| NO931917D0 (no) | 1993-05-26 |
| FI932445A (fi) | 1993-11-30 |
| FI101538B1 (fi) | 1998-07-15 |
| HUT66180A (en) | 1994-09-28 |
| TW268005B (el) | 1996-01-11 |
| DK0582368T3 (da) | 2001-02-05 |
| DE69329887T2 (de) | 2001-05-23 |
| FI932445A0 (fi) | 1993-05-28 |
| AU3980793A (en) | 1993-12-02 |
| CZ282783B6 (cs) | 1997-10-15 |
| JP3219541B2 (ja) | 2001-10-15 |
| EP0582368B1 (en) | 2001-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3035587T3 (en) | Thienobenzodiazepine derivatives for treatment of CNS disorders. | |
| IL100572A (en) | Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them | |
| PH25859A (en) | Composition for treatment of ischemic disorder | |
| HK143095A (en) | Imidazoline derivative and preparation thereof | |
| IL111275A0 (en) | Galanthamine derivatives, a process for their preparation and their use as medicaments | |
| FI102964B (fi) | Menetelmä terapeuttisesti käyttökelpoisen 4-substituoitu-1-(9,10-dihyd ro-9,10-metanoantrasen-9-yylimetyyli)piperidin-4-olijohdannaisen tuott amiseksi sekä menetelmän välituotteet | |
| HUT55385A (en) | Process for producing 3-piperazinyl-benzazol derivatives and pharmaceutical compositions containing them as active components | |
| EP0103320A3 (en) | Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them | |
| GR3020190T3 (en) | Diclofenac choline salt, a method for the preparation thereof and pharmaceutical compositions containing it | |
| HU9400908D0 (en) | Pharmaceutical compositions for treatng skin disorders | |
| GB8903036D0 (en) | Chemical compounds | |
| TW275629B (el) | ||
| HU9203052D0 (en) | Method for treatment of hypertension | |
| TW265342B (el) | ||
| ATE71364T1 (de) | Fluor enthaltende vitamin-d2-derivate. | |
| IL109227A0 (en) | Leustroducsin h, pharmaceutical composition containing the same, and processes for the preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |